Join to View Full Profile
Morgentau 12Buffalo City, WI 54622
Dr. Tsapas is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Aristotle University of Thessaloniki School of MedicineClass of 1992
Publications & Presentations
PubMed
- 34 citationsDapagliflozin decreases ambulatory central blood pressure and pulse wave velocity in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled clin...Eirini Papadopoulou, Charalampos Loutradis, Glykeria Tzatzagou, Kalliopi Kotsa, Ioanna Zografou
Journal of Hypertension. 2021-04-01 - 48 citationsGlucagon-like peptide-1 receptor agonists and sodium-glucose co-transporter-2 inhibitors as combination therapy for type 2 diabetes: A systematic review and meta-analy...Chrysanthi Mantsiou, Thomas Karagiannis, Panagiota Kakotrichi, Konstantinos Malandris, Ioannis Avgerinos
Diabetes, Obesity & Metabolism. 2020-10-01 - 90 citationsErratum. 2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Associati...John B. Buse, Deborah J. Wexler, Apostolos Tsapas, Peter Rossing, Geltrude Mingrone
Diabetes Care. 2020-05-22
Press Mentions
In Type 2 Diabetes, Weekly Semaglutide Reduced HbA1c and Increased Weight Loss More Than Weekly Exenatide ERApril 17th, 2018
New Diabetes Meds: The Year in ReviewFebruary 10th, 2016
Tirzepatide with Insulin Glargine Improves Type 2 DiabetesOctober 11th, 2023
Other Languages
- Greek
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
